 Connection
Bradley Haverkos to Lymphoma, Extranodal NK-T-Cell
This is a "connection" page, showing publications Bradley Haverkos has written about Lymphoma, Extranodal NK-T-Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.850 |
|
|
|
-
Haverkos BM, Porcu P. Improved outcomes for extranodal natural killer T-cell lymphoma. Lancet Haematol. 2020 04; 7(4):e272-e273.
Score: 0.708
-
Haverkos BM, Coleman C, Gru AA, Pan Z, Brammer J, Rochford R, Mishra A, Oakes CC, Baiocchi RA, Freud AG, Porcu P. Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL). Discov Med. 2017 03; 23(126):189-199.
Score: 0.576
-
Haverkos BM, Pan Z, Gru AA, Freud AG, Rabinovitch R, Xu-Welliver M, Otto B, Barrionuevo C, Baiocchi RA, Rochford R, Porcu P. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases. Curr Hematol Malig Rep. 2016 12; 11(6):514-527.
Score: 0.566
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|